TY  - JOUR

T1  - ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer

JO  - Molecular Cancer Therapeutics

UR  - https://doi.org/10.1158/1535-7163.1041.3.9

PY  - 2004/09/14

AU  - McCarty MF

AU  - Wey J

AU  - Stoeltzing O

AU  - Liu W

AU  - Fan F

AU  - Bucana C

AU  - Mansfield PF

AU  - Ryan AJ

AU  - Ellis LM

ED  - 

DO  - DOI: 10.1158/1535-7163.1041.3.9

PB  - American Association for Cancer Research (AACR)

VL  - 3

IS  - 9

SP  - 1041

EP  - 1048

Y2  - 2025/11/16

ER  -